Why Investors Don’t Trust Your Numbers and How to Fix It with Emily Stubbs
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
In this sharp and strategy-rich episode, I sit down with Emily Stubbs, a legal expert turned Visibility CFO—to unpack the real reasons many visionary founders struggle with growth, margins, and funding readiness.
Emily shares why popularity doesn’t equal profitability and how vague P&Ls are killing your ability to scale.
You’ll learn why segmentation in your finances isn't optional, how to spot when a service is a loss leader, and why having the right people and structure trumps having more people.
If you're a founder trying to grow sustainably, attract outside capital, or prepare for investor conversations, this episode is packed with game-changing insights you can’t afford to miss.
What You'll Learn in This Episode:
✅ How to identify what’s actually driving (or draining) your margin
✅ The power of segmented P&Ls and strategic visibility
✅ What most leaders misunderstand about AI, operations, and capacity
✅ Why founders must redefine what "working" looks like before scaling
✅ When to leverage fractional experts (like CFOs and growth strategists)
✅ How to stage your company for funding the way you’d stage a home for sale
Want to Keep Growing Without Losing Clients?
Here are 3 ways we can help you today:
Be a Featured Guest on the Provider’s Edge
Have traction and a story to share? Apply to join us on the show: PulsePointPath.com/Call-Sabrina
Make Your Pitch Investor-Ready
Send us your draft and let me rewrite it so it becomes a funding magnet 👉 PitchToYes.com
🚀 Get in Front of Investors Who Already Want What You’ve Built
Not every investor needs a white paper; they need a reason to believe.
Leveraging third-party validation is one of the easiest ways to create trust.
Nominate your company at 👉 HealthTechImpactAward.com before March 1, 2026 to win one of the six awards in digital health, diagnostics, biotech, mental health, women's health, and medical devices.